ANIP Insider Trading

Insider Ownership Percentage: 12.70%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $13,402,529.50

ANI Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at ANI Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$28ksoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$20M-$10M$0$10M$20MTotal Insider BuyingTotal Insider Selling

ANI Pharmaceuticals Share Price & Price History

Current Price: $69.21
Price Change: Price Increase of +0.01 (0.01%)
As of 04/17/2025 05:00 PM ET

This chart shows the closing price history over time for ANIP up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMarApr$69.21Closing price on 04/19/25:

SEC Filings (Institutional Ownership Changes) for ANI Pharmaceuticals (NASDAQ:ANIP)

76.05% of ANI Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ANIP by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$6.96Mbought$15MsoldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$100M-$50M$0$50M$100MTotal InflowsTotal Outflows
ANI Pharmaceuticals logo
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and mail order pharmacies, group purchasing organizations, specialty pharmacies, and hospitals. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Read More on ANI Pharmaceuticals

Today's Range

Now: $69.21
Low: $68.64
High: $70.48

50 Day Range

MA: $63.26
Low: $54.51
High: $69.55

52 Week Range

Now: $69.21
Low: $52.50
High: $70.48

Volume

299,660 shs

Average Volume

271,449 shs

Market Capitalization

$1.51 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.49

Who are the company insiders with the largest holdings of ANI Pharmaceuticals?

ANI Pharmaceuticals' top insider shareholders include:
  1. Meridian Venture Partners Ii L (Major Shareholder)
  2. Muthusamy Shanmugam (COO)
  3. Nikhil Lalwani (CEO)
  4. Chad Gassert (SVP)
  5. Stephen P Carey (CFO)
  6. James G Marken (SVP)
  7. Meredith Cook (VP)
  8. Christopher Mutz (Insider)
  9. Ori Gutwerg (SVP)
  10. Krista Davis (SVP)
  11. Antonio R Pera (Director)
  12. Renee P Tannenbaum (Director)
Learn More about top insider investors at ANI Pharmaceuticals.

Who are the major institutional investors of ANI Pharmaceuticals?

ANI Pharmaceuticals' top institutional investors include:
  1. Assenagon Asset Management S.A. — 0.53%
  2. GAMMA Investing LLC — 0.44%
  3. Rhumbline Advisers — 0.19%
  4. Wedge Capital Management L L P NC — 0.11%
  5. Summit Global Investments — 0.07%
  6. Kings Path Partners LLC — 0.05%
Learn More about top institutional investors of ANI Pharmaceuticals stock.

Which major investors are selling ANI Pharmaceuticals stock?

Within the previous quarter, ANIP stock was sold by these institutional investors:
  1. Assenagon Asset Management S.A.
  2. Wedge Capital Management L L P NC
  3. Kings Path Partners LLC
  4. Summit Global Investments
  5. BTC Capital Management Inc.
  6. Rhumbline Advisers
Within the previous year, company insiders that have sold ANI Pharmaceuticals company stock include:
  1. Meridian Venture Partners Ii L (Major Shareholder)
  2. Muthusamy Shanmugam (COO)
  3. Nikhil Lalwani (CEO)
  4. Chad Gassert (SVP)
  5. Stephen P Carey (CFO)
  6. James G Marken (SVP)
  7. Meredith Cook (VP)
  8. Christopher Mutz (Insider)
  9. Ori Gutwerg (SVP)
Learn More investors selling ANI Pharmaceuticals stock.

Which major investors are buying ANI Pharmaceuticals stock?

Within the last quarter, ANIP stock was purchased by institutional investors including:
  1. GAMMA Investing LLC
  2. Sowell Financial Services LLC
  3. GAMMA Investing LLC